NDC 71205-972

benzonatate

Benzonatate

benzonatate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Benzonatate.

Product ID71205-972_492a0004-9824-4df9-ab03-a46953aa4fdb
NDC71205-972
Product TypeHuman Prescription Drug
Proprietary Namebenzonatate
Generic NameBenzonatate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-03-22
Marketing CategoryANDA / ANDA
Application NumberANDA040749
Labeler NameProficient Rx LP
Substance NameBENZONATATE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71205-972-00

100 CAPSULE in 1 BOTTLE (71205-972-00)
Marketing Start Date2020-06-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71205-972-10 [71205097210]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-55 [71205097255]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-00 [71205097200]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-14 [71205097214]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-30 [71205097230]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-21 [71205097221]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-15 [71205097215]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

NDC 71205-972-20 [71205097220]

benzonatate CAPSULE
Marketing CategoryANDA
Application NumberANDA040749
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-04

Drug Details

NDC Crossover Matching brand name "benzonatate" or generic name "Benzonatate"

NDCBrand NameGeneric Name
0179-0237benzonatatebenzonatate
0440-1185benzonatatebenzonatate
0440-5185benzonatatebenzonatate
0440-5186benzonatatebenzonatate
0440-5187benzonatatebenzonatate
0440-7185benzonatatebenzonatate
0440-7186benzonatatebenzonatate
0615-1349BenzonatateBenzonatate
0615-7678BenzonatateBenzonatate
0615-7887benzonatatebenzonatate
0615-8143benzonatatebenzonatate
0615-8194benzonatatebenzonatate
0615-8403BenzonatateBenzonatate
0904-5904benzonatatebenzonatate
0904-5905benzonatatebenzonatate
0904-6564BenzonatateBenzonatate
0904-6657benzonatatebenzonatate
0904-7153BenzonatateBenzonatate
10135-632BenzonatateBenzonatate
10544-094benzonatatebenzonatate
10544-123benzonatatebenzonatate
10544-129benzonatatebenzonatate
11788-027benzonatatebenzonatate
11788-028benzonatatebenzonatate
11788-029benzonatatebenzonatate
67877-128benzonatatebenzonatate
67877-105benzonatatebenzonatate
67877-106benzonatatebenzonatate
67877-575benzonatatebenzonatate
67877-574benzonatatebenzonatate
67877-573benzonatatebenzonatate
68071-1891benzonatatebenzonatate
68071-1984benzonatatebenzonatate
68071-3185benzonatatebenzonatate
68071-1877BenzonatateBenzonatate
68071-3204benzonatatebenzonatate
68071-3346benzonatatebenzonatate
68071-4317benzonatatebenzonatate
68071-4105BenzonatateBenzonatate
68071-4258benzonatatebenzonatate
68071-4337benzonatatebenzonatate
68071-4276benzonatatebenzonatate
68151-2697BenzonatateBenzonatate
68382-247BenzonatateBenzonatate
68382-248BenzonatateBenzonatate
68788-6357BenzonatateBenzonatate
68788-7014BenzonatateBenzonatate
68788-6839BenzonatateBenzonatate
68788-7087benzonatatebenzonatate
68788-7094benzonatatebenzonatate
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.